Hera News & Events

­

Bacterial Carriers Offer New Hope in the Treatment of Glioblastoma

Unlike many cancers, which have seen a tremendous increase in [...]

Rat Models Provide Superior Insights into Mutagenic/Carcinogenic Responses in Humans

Although in-vitro bacterial mutation assays and murine models have long [...]

Chimeric Humanized Mouse Models: Understanding Human and Mouse Cell Interactions

Humanized liver mouse models are increasingly being used in preclinical [...]

Transposon Mutagenesis Helps Identify Genes Mediating Drug Resistance in the Treatment of CLL

First time treatment of Chronic Lymphocratic Leukemia (CLL) generally requires [...]

PDX Models of Lung Cancer Closely Mimic Characteristics of Patient Primary Tumors

Despite ongoing research, lung cancers have remained among the most [...]

Rat Provides a More Robust & Convenient Animal Infection Model for Hepatitis E Virus

Hepatitis E virus (HEV) is estimated to cause more than 56 thousand deaths each year, and although most infections remain asymptomatic, HEV is still considered one of the most common causes of acute viral hepatitis and is an ongoing concern for immunosuppressed transplant patients.

Orthoptopic vs. Subcutaneous Xenograft Models of Human PC-3 Prostate Cancer

Subcutaneously implanted patient-derived xenografts (PDX) have become a commonly used [...]

HIV-1 Gene Therapies Considered: RNAi versus CRISPR-cas

Though human immunodeficiency virus type 1 (HIV-1) can now be [...]

Hera BioLabs, a KY based contract research lab announces $400K Kentucky SBIR/STTR Matching Funds Grant

Hera BioLabs (“Hera”), a Lexington KY based contract research organization [...]

Transgenic Rats as Research Models Boast Significant Benefits….

Transgenic Rats as Research Models Boast Significant Benefits over Mouse [...]